DK75177A - Fremgangsmade til fremstilling af prostaglandiner - Google Patents

Fremgangsmade til fremstilling af prostaglandiner

Info

Publication number
DK75177A
DK75177A DK75177A DK75177A DK75177A DK 75177 A DK75177 A DK 75177A DK 75177 A DK75177 A DK 75177A DK 75177 A DK75177 A DK 75177A DK 75177 A DK75177 A DK 75177A
Authority
DK
Denmark
Prior art keywords
prostaglandins
procedures
production
Prior art date
Application number
DK75177A
Other languages
Danish (da)
English (en)
Inventor
R Wenger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK75177A publication Critical patent/DK75177A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK75177A 1976-04-27 1977-02-21 Fremgangsmade til fremstilling af prostaglandiner DK75177A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH526876 1976-04-27

Publications (1)

Publication Number Publication Date
DK75177A true DK75177A (da) 1977-10-28

Family

ID=4290745

Family Applications (1)

Application Number Title Priority Date Filing Date
DK75177A DK75177A (da) 1976-04-27 1977-02-21 Fremgangsmade til fremstilling af prostaglandiner

Country Status (13)

Country Link
JP (1) JPS52131600A (ru)
BE (1) BE852055A (ru)
DE (1) DE2707915A1 (ru)
DK (1) DK75177A (ru)
FI (1) FI770572A (ru)
FR (2) FR2353549A1 (ru)
GB (1) GB1577647A (ru)
IL (1) IL51561A0 (ru)
NL (1) NL7702221A (ru)
NZ (1) NZ183462A (ru)
PT (1) PT66269B (ru)
SU (1) SU741794A3 (ru)
ZA (1) ZA771215B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds

Also Published As

Publication number Publication date
NZ183462A (en) 1979-10-25
DE2707915A1 (de) 1977-11-17
ZA771215B (en) 1978-10-25
SU741794A3 (ru) 1980-06-15
FI770572A (ru) 1977-10-28
IL51561A0 (en) 1977-04-29
BE852055A (fr) 1977-09-05
NL7702221A (nl) 1977-10-31
PT66269A (en) 1977-04-01
GB1577647A (en) 1980-10-29
FR2355837A1 (fr) 1978-01-20
PT66269B (en) 1978-11-07
JPS52131600A (en) 1977-11-04
FR2353549A1 (fr) 1977-12-30

Similar Documents

Publication Publication Date Title
DK492677A (da) Fremgangsmaade til fremstilling af substituerede benzam9der
PL195154A1 (pl) Sposob wytwarzania eterow zwiazkow hydroksybenzodwuheterocyklicznych
DK149062C (da) Analogifremgangsmaade til fremstilling af cefuroximestere
DK147777A (da) Fremgangsmade til fremstilling af acylchromaner
DK354678A (da) Fremgangsmaade til fremstilling af propenylaminer
DK589276A (da) Fremgangsmade til fremstilling af ensymholdige dyrefodermidler
DK190275A (da) Fremgangsmade til fremstilling af humleolie
DK46777A (da) Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder
DK435477A (da) Fremgangsmaade til fremstilling af funktionaliserede celluloser
DK144177A (da) Fremgangsmade til fremstilling af acylayanider
DK273376A (da) Fremgangsmade til fremstilling af 11-desoxy-16-aryloxy-omega-pentanorprostaglandiner
DK446277A (da) Fremgangsmaade til fremstilling af orthoeddikesyrealkylestere
DK476277A (da) Fremgangsmaade til fremstilling af krydslaminater
DK476377A (da) Fremgangsmaade til fremstilling af krydslaminater
DK97877A (da) Fremgangsmade til fremstilling af urinstofderivater
DK575576A (da) Fremgangsmade til fremstilling af krystallinske former af natrium-cefamandol
DK87977A (da) Fremgangsmade til fremstilling af benzylestere
DK65877A (da) Fremgangsmaade til fremstilling af mikrokapsler
DK502077A (da) Fremgangsmaade til fremstilling af gammapyroner
DK73977A (da) Fremgangsmade til fremstilling af d-homosteroider
DK551677A (da) Fremgangsmaade til fremstilling af prostaglandinanaloge
DK379277A (da) Fremgangsmaade til fremstilling af prostaglandinanaloge
DK417477A (da) Fremgangsmaade til fremstilling af urethaner
DK77179A (da) Fremgangsmaade til fremstilling af androstadiener
DK541776A (da) Fremgangsmade til fremstilling af prostaglandiner